Celldex to Present at Upcoming Investor Conferences

Article Stock Quotes (1)

FREE Breaking News Alerts from StreetInsider.com!

StreetInsider.com Top Tickers, 6/24/2026

1. SPCX
2. SPY
3. FDX
4. ABBV
5. META

6. IBM
7. NKE
8. MU
9. PFE
10. AWK

Get Alerts CLDX Hot Sheet

Price: $32.98 -1.29%

Overall Analyst Rating:
SELL (= Flat)

EPS Growth %: -23.5%

Join SI Premium – FREE

HAMPTON, N.J., Nov. 07, 2025 (GLOBE NEWSWIRE) -- Celldex (NASDAQ: CLDX) announced today that management will participate in fireside chats at the following upcoming investor conferences:

Guggenheim 2nd Annual Healthcare Innovation Conference on Tuesday, November 11 at 10:00 am ET
TD Cowen Immunology & Inflammation Summit on Thursday, November 13 at 9:30 am ET
8th Annual Evercore Healthcare Conference on Tuesday, December 2 at 3:00 pm ET

Live webcasts of the presentations will be available on the "Events & Presentations" page of the "Investors" section of the Celldex website. Replays will be available for 90 days following the event.

About Celldex
Celldex is pioneering new horizons in immunology to deliver life-changing therapies. We are relentless in our pursuit of novel antibody-based treatments that engage the human immune system and directly affect critical pathways to improve the lives of patients with allergic, inflammatory and autoimmune disorders.
Visit www.celldex.com.

Company Contact
Sarah Cavanaugh
Senior Vice President, Corporate Affairs & Administration
(508) 864-8337
[email protected]

Patrick Till
Meru Advisors
(484) 788-8560
[email protected]